Search Results

Equip your research team with expert-led GPCR pharmacology training. Shared depth in GPCR pharmacology—built for scientific teams One team membership. Shared pharmacology expertise. Faster, better decisions. Access monthly courses, live AMAs, and hard-won insight from 40+ years shaping GPCR pharmacology. Expert-Level Mastery — Advanced Pharmacology Live AMA Sessions with Terry

, pharmacology, signaling, and drug discovery. Who should attend these GPCR pharmacology webinars? GPCR platform. Do I need prior knowledge of GPCR pharmacology? These webinars are designed to support ongoing scientific development in GPCR pharmacology and drug discovery on receptor pharmacology and drug discovery.

through empowerment and purpose. << Back to podcast list Strategic Partner(s) GPCR Pharmacology, Career Starting at DuPont, then BMS, Novartis, and eventually founding in vitro pharmacology departments, Sokhom Falling in Love with GPCRs GPCR pharmacology captured his scientific curiosity. Sokhom recalls how binding assays at BMS introduced him to the depth and complexity of receptor pharmacology He blends classical receptor pharmacology with biosensor technology, always adapting to new tools and

Graciela Pineyro’s love for GPCR pharmacology started in Uruguay where she first worked on the serotonin This interest in research and pharmacology took Graciela to Canada where she stayed ever since she arrived Graciela has done extensive work on the molecular pharmacology of opioid receptors, exploring their signaling Today, Graciela and her team’s efforts are directed towards the characterization of the pharmacological GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

Sachdev pursued Ph.D. in the same lab where she investigated the molecular pharmacology of cannabinoid She is also very active within the pharmacology community and currently serves on the editorial board of the British Journal of Pharmacology. Given her expertise in GPCR pharmacology and scientific communication, she is poised to make valuable GPCR Enjoying the Dr. GPCR Podcast? Leave a Review.

Since then Oliver has worked at the University of Geneva, where his research on peptide engineering and GPCR pharmacology has led to a series of high-profile publications and new intellectual property, and at GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review. Better Questions in Science: A Practical Guide for Emerging Researchers When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology Thanks

Juan José Fung is a Principal Scientist at GPCR Therapeutics, Inc , a drug discovery company focused Brian Kobilka , studying the dimerization of GPCRs. Dr. pharmacology. Juan José Fung on the web LinkedIn GPCR Therapeutics Dr. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

Soon About Louis Gendron "Dr Louis Gendron, PhD is tenured Professor and Chair of the Department of Pharmacology-Physiology He has 20+ years of experience in in vitro and in vivo GPCR pharmacology and has published seminal papers potential proteins interacting with GPCRs. GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires 22nd GPCR Retreat Sponsored by

pharmacology Data ❌ Suboptimal CRO Partnerships ❌ Stalled Pipeline Progression ❌ Uncertainty in GPCR Actionable Scientific Validation: Ensure target companies execute the right GPCR pharmacology experiments Biology-First, Data-Driven Solutions Every recommendation is rooted in GPCR biology, pharmacology experience With over two decades dedicated to GPCR pharmacology across biotech, academia, and the non-profit sector Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution

GPCR Ecosystem – the ultimate hub for GPCR professionals to connect, collaborate, and advance drug discovery Home: About Accelerating GPCR Drug Discovery, Together Dr. GPCR is the global hub where academia and industry meet to advance GPCR research, accelerate drug discovery 🔒 Terry's Corner ➚ 🔒 GPCR Weekly News ➚ Dr. GPCR Podcast ➚ Articles from the Ecosystem ➚ First AMA of 2026: GPCR Pharmacology, Biased Signaling &

Gunnar Schulte Gunnar Schulte is a Professor in receptor pharmacology and research group leader for the section Receptor Biology and Signaling at the Department of Physiology and Pharmacology. pharmacology; 2006) before starting his independent research team "Receptor Biology & Signalling" in , British Journal of Pharmacology, Pharmacological Reviews, and The Journal of Biological Chemistry. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

I sat down with Kevin to chat about GPCRs, pharmacology, and his contributions to the field in both the binding and function at the molecular and cellular levels over the last 20 years, particularly involving GPCRs He is Head of Molecular Endocrinology and Pharmacology at the UWA Centre for Medical Research and Harry and Toxicologists and is a member of the British Pharmacological Society International Advisory Group GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

Katarina Nemec " I am a pharmacist with an interest in systems pharmacology and precision medicine. pharmacology while performing various cell-based experiments to understand the binding, activation, and signaling of therapeutically relevant GPCRs. discovery and adopt data science methodology to tackle relevant scientific questions on the systems pharmacology GPCR Enjoying the Dr. GPCR Podcast? Leave a Review.

In 2005 he started working on the development of conformational thermostabilization of GPCRs, which resulted Subsequent work has focused on understanding the molecular basis of GPCR pharmacology through structure In 2016 mini-G proteins were developed as a tool for the structure determination of GPCRs in the fully Recent work includes the first structure determination of a GPCR bound to a biased agonist and coupled GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review.

Explore GPCR lipid rafts, bitter taste receptor pharmacology, and data integration in this expert interview roles in disease When integrating computational predictions with real-world pharmacological readouts , then completed his graduate education in cellular and molecular medicine with a specialization in pharmacology Sedaghat has accumulated over two decades of teaching and research in pharmacology, contributing as a pharmacology.

pharmacology. during grad school at the University of Minnesota laid the groundwork for his current work in GPCR pharmacology GPCRs and the Opioid Crisis: A New Pharmacological Frontier Now at the University of Michigan, Ben focuses Scientific Rigor: The Value of ‘Old School’ Pharmacology Despite the availability of modern tools, Ben Key Takeaway This Episode with Ben Clements is a deep dive into the pharmacological potential of GPCRs

Why targeting the pharmacologically relevant surface-exposed receptor pool changes the way scientists interpret GPCR trafficking. These years shaped his interest in ion channels, GPCR pharmacology, and the chemical strategies needed Since 2020, JB has led his research group at the Leibniz Research Institute for Molecular Pharmacology Broichhagen on the Web LinkedIn Google Scholar Lab Website Leibniz Research Institute for Molecular Pharmacology

Sachdev pursued Ph.D. in the same lab where she investigated the molecular pharmacology of cannabinoid She is also very active within the pharmacology community and currently serves on the editorial board of the British Journal of Pharmacology. Given her expertise in GPCR pharmacology and scientific communication, she is poised to make valuable Biology and Pharmacology from Monash University.

academia, building translational experiments, and using real-world data to drive impactful science in the GPCR How GPCR pharmacology connects molecular insights to real-world interventions. how fentanyl and xylazine shut down breathing through different mechanisms—work that blends receptor pharmacology now and see how one scientist is turning molecules into a mission, bridging the gap between receptor pharmacology GPCR Podcast? Leave a Review.

Explore the Masterclass Pharmacology Foundations Build the essential lens every scientist needs to see pharmacology clearly, from core principles to the hidden variables of drug disposition. Agonists, Antagonists & Core Mechanisms Master the classic players in GPCR pharmacology and learn how The classes are designed for researchers, students, and professionals in biology, pharmacology, and biochemistry Masterclasses cover a variety of track including but not limited to pharmacology foundations, agonists

GPCR Ecosystem: uniting scientists, biotech, and innovators to advance GPCR research worldwide. GPCR Ecosystem We unite the GPCR Community to advance drug discovery Where GPCR Experts Move Science GPCR began as a podcast. GPCR Symposium with over 100 attendees 2024 GPCR University Launched comprehensive courses and expert pharmacology ✔ Sam Hoare, simplifying GPCR data analysis ✔ Global CROs and biotech leaders, contributing

and Pharmacology-Enabling Drug Discovery Laurent Sabbagh Characterizing hADGRE5/CD97 Activation and across different species, we plan to adapt this technology for high-throughput screening of pharmacological Signaling and Pharmacology-Enabling Drug Discovery Laurent Sabbagh Abstract "The 3rd generation bioSens-All Department of Pharmacology-Physiology, Université de Sherbrooke, Sherbrooke, Quebec, Canada 2. Our research aims to leverage this knowledge to identify novel pharmacological targets and contribute

Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program ADGRG1/GPR56 regulates survival of terminally differentiated CD8+ T cells Cheng-Chih Hsiao Adhesion GPCR University Medical Center Hamburg-Eppendorf" About Anastasia Georgiadi "Head of Junior Group Endocrine Pharmacology Cell and Molecular Biology, Karolinska Institute, Sweden" Anastasia Georgiadi on the web Endocrine Pharmacology In all, research in the Tilley lab spans molecular pharmacology to pathophysiology studies focused primarily

Explore Martin Marro’s impact on GPCR drug discovery, assay innovation, and translational pharmacology Martin Marro, currently Executive Director and Head of Cell Pharmacology at Eli Lilly’s Obesity Research What learning from “failed” screens can reveal about receptor pharmacology and species selectivity. pharmacology. Martin Marro leads the Cell Pharmacology group in the Diabetes, Obesity and Complications Therapeutic

, assay design, and pharmacology—skills you won't find in any textbook or paper. ⧖ 20+ Hours of Expert Terry Kenakin Terry's Corner Author of 'A Pharmacology Primer', the definitive GPCR reference used by Pioneer in quantitative pharmacology methods. Dr. Yamina Berchiche Dr. enough depth to satisfy the hunger for theory while being full of practical knowledge Anonymous The best pharmacology Also super-valuable for those of us learning how to teach pharmacology Anonymous Dr.

Home Registration Full Agenda Venue Travel Tips Sponsors Special Issue on Adhesion GPCRs CINVESTAV, Mexico City, Mexico October 23-25 Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October Read More 12:00 PM Coffee Break with lights snacks Read More 12:30 PM State of the Art Talk Adhesion GPCR Signaling and Pharmacology-Enabling Drug Discovery Fabian Pohl Structural Determinants Of GAIN Domain map of thermogenic fat Gavin Zhang NovoiSMART - A new platform for GPCR antibody drug discovery

Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program signaling pathway of the ADGRA homolog Remoulade in Drosophila Beatriz Blanco Redondo The Adhesion GPCR The mammalian Remo homolog ADGRA2/Gpr124 cooperates with other GPCRs of the Frizzled family, and the Knowledge of the structural dynamics of this complex is limited and pharmacological and in vivo systems as a model organism for future pharmacological applications."

Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program Activation: Direct Communication of Extracellular Region with Transmembrane Domain in a Holo-Adhesion GPCR Departments of Psychiatry and Molecular Pharmacology and Therapeutics, Columbia University Vagelos College Tall Department of Pharmacology, University of Michigan "" About Frank Kwarcinski "I am research faculty within the department of Pharmacology at the University of Michigan.

About Yuling Feng "I am currently a postdoctoral research fellow working with aGPCR pharmacology and My research focuses on understanding the molecular mechanisms of adhesion GPCRs (aGPCRs) in lymphatic GPCR Adhesion GPCR BAI1/ADGRB1 can block IGF1R-mediated growth signalling, increase radiosensitivity Like many other aGPCRs, ADGRG6 undergoes autoproteolysis at the GPCR-autoproteolysis site (GPS) enclosed unclear which domains of ADGRG6 are N-glycosylated and how this might affect the overall molecular pharmacology

He then moved to the National Institute of Mental Health, researching pharmacological mechanisms of Class Today, Sam is a pharmacology data analyst and the founder of Pharmechanics LLC , a consultancy and data in vitro pharmacology data to advance drug discovery. Hoare was a pharmacology leader in the pharmaceutical industry for 15 years at Neurocrine Biosciences Sam is known for demystifying complicated and newly-emerging pharmacology concepts, enabling them to